Synonyms: Austedo® | SD-809 | SD809 | tetrabenazine D6
deutetrabenazine is an approved drug (FDA (2017))
Compound class:
Synthetic organic
Comment: This is an orally available, deuterated analogue of tetrabenazine which can be administered in lower doses and in a simplified dosing regimen. Deutetrabenazine is the first ever deuterated drug to be approved.
In drug discovery, replacing hydrogen atoms in drug compounds with deuterium (deuteration) is a technique employed to inhibit degradation of the drug and its active metabolites. The presence of the deuterium atoms attenuates CYP2D6-driven metabolic breakdown of the compound. This effects an increase in circulating half-lives and improves the duration of therapeutic effect and decreases the dose required to achieve therapeutic concentration [4]. |
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes (FDA (2017)) |
IUPAC Name |
(3R,11bR)-3-(2-methylpropyl)-9,10-bis(trideuteriomethoxy)-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one |
International Nonproprietary Names | |
INN number | INN |
10069 | deutetrabenazine |
Synonyms |
Austedo® | SD-809 | SD809 | tetrabenazine D6 |
Database Links | |
CAS Registry No. | 1392826-25-3 (source: WHO INN record) |
GtoPdb PubChem SID | 252827365 |
PubChem CID | 73437646 |
Search Google for chemical match using the InChIKey | MKJIEFSOBYUXJB-VFJJUKLQSA-N |
Search Google for chemicals with the same backbone | MKJIEFSOBYUXJB |
Search PubMed clinical trials | deutetrabenazine |
Search PubMed titles | deutetrabenazine |
Search PubMed titles/abstracts | deutetrabenazine |
UniChem Compound Search for chemical match using the InChIKey | MKJIEFSOBYUXJB-VFJJUKLQSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | MKJIEFSOBYUXJB-VFJJUKLQSA-N |